Alder Hos raske ældre forsøgspersoner (≥ 70 år) steg den samlede eksponering for vildagliptin (100 mg en gang daglig) med 32%, og den maksimale plasmakoncentration steg med 18% sammenlignet med unge raske forsøgspersoner (18- 40 år).
Age In healthy elderly subjects (≥ 70 years), the overall exposure of vildagliptin (100 mg once daily) was increased by 32%, with an 18% increase in peak plasma concentration as compared to young healthy subjects (18-40 years).